Results 21 to 30 of about 10,882 (150)

Assessing the Impact of Rilonacept on Lipid Profiles in Patients With Recurrent Pericarditis [PDF]

JACC: Advances
Aqieda Bayat, MD, Ankit Agrawal, MD, Ashwin Kumar, MD, Muhammad Majid, MD, Beni Verma, MD, Abdullah Yesilyaprak, MD, Allan L. Klein, MD   +6 more
doaj   +2 more sources

Interleukin-1 Antagonists for the Treatment of Recurrent Pericarditis. [PDF]

BioDrugs, 2022
Abadie BQ, Cremer PC.
europepmc   +3 more sources

Recurrent Pericarditis and Paradigm Shift in Cardiovascular Imaging and Targeted Therapeutics. [PDF]

JACC Adv
Karmali R, Kafil TS, Bayat A, Honnekeri B, Badwan O, Berglund F, Cremer P, Klein AL.   +7 more
europepmc   +2 more sources

Pericarditis as an onset of cancer

Рациональная фармакотерапия в кардиологии, 2023
Pericarditis is an inflammation of the heart serous membrane of an infectious or non-infectious nature. Secondary pericardial effusion can be one of the few signs of cancer of the lung, pleura or breast in young people, while early treatment of the ...
D. F. Mesitskaya, S. A. Panov, D. A. Andreev, A. N. Volovchenko, A. Sh. Dumikyan   +4 more
doaj   +1 more source

Use of Anakinra in steroid dependent recurrent pericarditis: a case report and review of literature

Journal of Community Hospital Internal Medicine Perspectives, 2021
Non-steroidal anti-inflammatory drugs and colchicine are the cornerstone treatment for recurrent pericarditis. Corticosteroids are frequently used in patients with recurrent episodes of pericarditis.
Vinay Kumar Thallapally, Sonia Gupta, Sai Giridhar Gundepalli, Joseph Nahas   +3 more
doaj   +1 more source

Recurrent Pericarditis in a Woman With Acromegaly Responding Favorably to Transsphenoidal Surgery. [PDF]

AACE Clin Case Rep
Jacobson S, Stetco JR, Garfield N.
europepmc   +2 more sources

Interleukin‐1 Trap Rilonacept Improved Health‐Related Quality of Life and Sleep in Patients With Recurrent Pericarditis: Results From the Phase 3 Clinical Trial RHAPSODY

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Recurrent pericarditis is characterized by painful flares and inflammation, which negatively impact health‐related quality of life. RHAPSODY (rilonacept inhibition of interleukin‐1 alpha and beta for recurrent pericarditis: a pivotal ...
Antonio Brucato, Michelle Z. Lim‐Watson, Allan Klein, Massimo Imazio, David Cella, Paul Cremer, Martin M. LeWinter, Sushil Allen Luis, David Lin, Dor Lotan, Massimo Pancrazi, Lucia Trotta, Brittany Klooster, Leighann Litcher‐Kelly, Liangxing Zou, Matt Magestro, Alistair Wheeler, John F. Paolini   +17 more
doaj   +1 more source

Una presentación atípica y grave de síndrome poliglandular autoinmune tipo 2

Galicia Clínica, 2022
Background: Recurrent pericarditis has been described as an unusual manifestation of autoimmune polyglandular syndrome type 2 (APS 2). Case report: We describe a case of a 44-year-old woman who was admitted to hospital due to 5 pericarditis, 3 of them ...
Andrea Riaño Pérez, Carles García Cervera, Jorge Peris García, Vicente Giner Galvañ   +3 more
doaj   +1 more source

Management of Recurrent Pregnancy-Related Pericarditis

Case Reports in Cardiology, 2022
The evidence on recurrent pregnancy-related pericarditis is limited, and management strategies are based on case reports and expert opinion. We describe a patient with myopericarditis complicated by cardiac tamponade presenting shortly after her first ...
Michel Ibrahim, Michael Fattouh, Alice Jacobs   +2 more
doaj   +1 more source

US Database Study of Clinical Burden and Unmet Need in Recurrent Pericarditis

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Patients with recurrent pericarditis (RP) may develop complications, multiple recurrences, or inadequate treatment response. This study aimed to characterize disease burden and unmet needs in RP.
Allan Klein, Paul Cremer, Apostolos Kontzias, Muhammad Furqan, Ryan Tubman, Mike Roy, Michelle Z. Lim‐Watson, Matthew Magestro   +7 more
doaj   +1 more source